# Unifortune

> Unifortune is a VC fund in Beijing backing Health Care, Energy and Automotive. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 7
- Last investment: Oct 2023
- Lead investor: 0%
- Last updated: Aug 2026
- Website: https://www.unifgroup.com/guanYuWoMen.html

Unifortune is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 43% |
| Energy | 1 | 14% |
| Automotive | 1 | 14% |
| Biotechnology | 1 | 14% |
| Energy Storage | 1 | 14% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 4 | 57% |
| Angel | 1 | 14% |
| Series A | 1 | 14% |
| Series D | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Atom Bioscience & Pharmaceutical | Atom Bioscience is a clinical-stage biotechnology company developing new treatments for inflammatory and metabolic diseases such as chronic gout and non-alcoholic steatohepatitis. | $82.1M | Series D | Oct 16, 2023 |  |
| Immvira | Immvira was founded in Shenzhen China in May of 2015 by Prof. Bernard Roizman of University of Chicago and Prof. Grace Zhou formerly a Research Associate Professor at University of Chicago, Prof. Thomas Shenk of Princeton University, Prof. Richard Whitley of University of Alabama, Prof. Ralph Weichselbaum of University of Chicago. |  | Series C | Oct 26, 2022 |  |
| Guorun Energy Storage | Guorun Energy Storage is an enterprise focusing on the manufacture of all-vanadium flow battery equipment and the production of core diaphragm materials for flow batteries, electrolyzed water for hydrogen production and hydrogen fuel cells. The two core products are all-vanadium flow energy storage battery products and perfluorinated ion membrane. | $7.4M | Angel | Aug 08, 2022 |  |
| CiDi | CiDi is a smart and intelligent automotive technology research and development company. | $45M | Series C | May 06, 2022 |  |
| CART Medical | CART Medical Technologies, Ltd. is a high-tech company specializing in the development and application of new technologies for immune cell therapy. It has a 2,200 square meter GMP laboratory and research and development laboratory. | $11.1M | Series A | Mar 09, 2022 |  |
| Atom Bioscience & Pharmaceutical | Atom Bioscience is a clinical-stage biotechnology company developing new treatments for inflammatory and metabolic diseases such as chronic gout and non-alcoholic steatohepatitis. | $45M | Series C | Jan 05, 2022 |  |
| LenoMed Medical | LenoMed Medical is a medical equipment maker.Over 15-year research and development experience on infusion technology, LenoMed innovatively develop and manufacture InnoTech insulin pump, drug infusion pump and disposables.They explore innovative way to develop close-loop through integration of CGM technology and insulin pump. They share thecommitment to advance diabetes management through their diabetes care management system. |  | Series C | May 12, 2021 |  |

7 of 7 investments shown.

## Co-investors
- [Kaitai Capital](https://shizune.co/investors/profile/kaitai-capital) — VC Fund, 2 deals together
- [Baidu Ventures](https://shizune.co/investors/profile/baidu-ventures) — VC Fund, 1 deal together
- China Merchants China Direct Investments — VC Fund, 1 deal together
- Chuang He Hui Mao — VC Fund, 1 deal together
- [Crown Asia Investment](https://shizune.co/investors/profile/crown-asia-investment) — VC Fund, 1 deal together
- [EFung Capital](https://shizune.co/investors/profile/efung-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Unifortune invest in?

Unifortune invests primarily in Health Care, Energy and Automotive startups, most often at Series C and Angel stage. Most of the 7 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Unifortune last invest?

The most recent investment recorded for Unifortune closed in Oct 2023. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co